Evidence map›Paper›PMID 32456416›Full record

ArticleJournal of the American Chemical Society2020

Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and

Bruno L Oliveira, Benjamin J Stenton, V B Unnikrishnan, Cátia Rebelo de Almeida, João Conde, Magda Negrão, Felipe S S Schneider, Carlos Cordeiro, Miguel Godinho Ferreira, Giovanni F Caramori and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Exploring New Bioorthogonal Catalysts: Scaffold Diversity in Catalysis for Chemical Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  11. Review
  12. Repurposing Copper(II)/THPTA as A Bioorthogonal Catalyst for Thiazolidine Bond Cleavage.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Article
  14. Article
  15. Antibody-Drug Conjugates-Evolution and Perspectives.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Bruno L OliveiraDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Benjamin J StentonDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
V B UnnikrishnanDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Cátia Rebelo de AlmeidaChampalimaud Centre for the Unknown, Champalimaud Foundation, Avenida Brasilia, 1400-038 Lisboa, Portugal.
João CondeInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.ORCID 0000-0001-8422-6792
Magda NegrãoChampalimaud Centre for the Unknown, Champalimaud Foundation, Avenida Brasilia, 1400-038 Lisboa, Portugal.
Felipe S S SchneiderDepartment of Chemistry, Federal University of Santa Catarina-UFSC, Campus Trindade, Florianópolis, Santa Catarina 88040-900, Brazil.ORCID 0000-0001-8090-2976
Carlos CordeiroLaboratório de FT-ICR e Espectrometria de Massa Estrutural, Faculdade de Ciências da Universidade de Lisboa, Campo-Grande, 1749-016 Lisboa, Portugal.
Miguel Godinho FerreiraChampalimaud Centre for the Unknown, Champalimaud Foundation, Avenida Brasilia, 1400-038 Lisboa, Portugal.
Giovanni F CaramoriDepartment of Chemistry, Federal University of Santa Catarina-UFSC, Campus Trindade, Florianópolis, Santa Catarina 88040-900, Brazil.ORCID 0000-0002-6455-7831
Josiel B DomingosDepartment of Chemistry, Federal University of Santa Catarina-UFSC, Campus Trindade, Florianópolis, Santa Catarina 88040-900, Brazil.ORCID 0000-0002-6001-4522
Rita FiorChampalimaud Centre for the Unknown, Champalimaud Foundation, Avenida Brasilia, 1400-038 Lisboa, Portugal.
Gonçalo J L BernardesDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.ORCID 0000-0001-6594-8917
Champalimaud Foundation · PTUniversity of Lisbon · PTUniversidade Federal de Santa Catarina · BRUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability to create ways to control drug activation at specific tissues while sparing healthy tissues remains a major challenge. The administration of exogenous target-specific triggers offers the potential for traceless release of active drugs on tumor sites from antibody-drug conjugates (ADCs) and caged prodrugs. We have developed a metal-mediated bond-cleavage reaction that uses platinum complexes [K

Indexed as

AmidesAnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationCisplatinDrug LiberationDrug Screening Assays, AntitumorHumansMolecular StructureMorphinansNeoplasms, ExperimentalPlatinumZebrafishAmidesAntineoplastic AgentsCisplatinMorphinansN-propargylPlatinum

Identifiers

PMID32456416
PMCPMC7304066
OpenAlexW3030229048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.